Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000216 · ClinicalTrials.gov registry record · Phase 3
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00000216: Completed Phase 3 study, sponsored by Yale University.
NCT00000216 is a Phase 3 study that has completed, run by Yale University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000216, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to compare the clinical efficacy of maintenance on low and high doses of buprenorphine with methadone for cocaine abusing opiate addicts.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2005-01 |
| Phase | Phase 3 |
What the finished NCT00000216 record still lists
NCT00000216 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000216 about?
NCT00000216 is a clinical study titled "Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1". The purpose of this study is to compare the clinical efficacy of maintenance on low and high doses of buprenorphine with methadone for cocaine abusing opiate addicts.
What is the current status of trial NCT00000216?
This trial is currently completed. It is a Phase 3 study. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00000216?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000216?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.